ZURA Stock Analysis: Buy, Sell, or Hold?
ZURA - Zura Bio Limited Class A Ordinary Shares
$4.13
0.13 (3.25%)
▲
5d:
-6.35%
30d:
-8.43%
90d:
-21.93%
HOLD
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 12, 2026
20d
Get Alerted When ZURA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ZURA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ZURA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ZURA is currently trading at $4.13, which is considered fair relative to its 30-day fair value range of $3.93 to $4.55.
Technical Outlook: Technically, ZURA is showing sideways momentum. Immediate support is located at $3.77, while resistance sits at $4.78. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: ZURA scores 78/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.00 (+335.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ZURA is showing sideways momentum. Immediate support is located at $3.77, while resistance sits at $4.78. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: ZURA scores 78/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.00 (+335.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.93 -
$4.55
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (78/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 335.8% below Wall St target ($18.00)
- BULLISH: Bottoming setup score 78/100 — corrected, stabilizing, and turning up
- CAUTION: Recommendation downgraded due to -6.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$3.93 -
$4.55
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.77
Resistance Level
$4.78
Current Trend
Sideways
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.99
Wall Street Target
$18.00
(+335.8%)
Share & Embed Analysis
Last updated: October 22, 2026 6:29 AM ET
Data refreshes hourly during market hours. Next update: 7:29 AM
Data refreshes hourly during market hours. Next update: 7:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZURA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 47 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 71 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 50 HOLD |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 63 BUY |
